BRIEF published on 12/27/2024 at 07:35, 1 year 4 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 4 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 5 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 1 year 7 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 1 year 7 months ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 7 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
Published on 05/01/2026 at 14:00, 50 minutes ago CCL Industries Closing of ALT Technologies Acquisition
Published on 05/01/2026 at 14:00, 50 minutes ago Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions
Published on 05/01/2026 at 13:01, 1 hour 49 minutes ago BeMetals Announces Resumption of Trading on TSX Venture Exchange and Effective Date of Share Consolidation
Published on 05/01/2026 at 13:00, 1 hour 50 minutes ago Abasca Resources to Participate in Core Days 2026 and Closes $2.5 Million Private Placement
Published on 05/01/2026 at 07:35, 7 hours 15 minutes ago Snipp Interactive Reports Financial Results for Q4 and Fiscal 2025; Announces Conference Call on May 5, 2026
Published on 05/01/2026 at 14:15, 35 minutes ago Custodian Property Income REIT plc: Total Voting Rights
Published on 05/01/2026 at 14:05, 44 minutes ago International Jazz Day 2026 Worldwide Celebration Concludes with Thrilling All-Star Global Concert from Chicago
Published on 05/01/2026 at 14:00, 50 minutes ago Nebius Group announces date of first quarter 2026 results and conference call
Published on 05/01/2026 at 13:50, 59 minutes ago Curaleaf Announces Appointment of Torsten Greif to Board of Directors
Published on 05/01/2026 at 13:25, 1 hour 24 minutes ago Nebius agrees to acquire Eigen AI, strengthening Nebius Token Factory as a frontier inference platform
Published on 04/30/2026 at 20:00, 18 hours 49 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 19 hours 34 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 19 hours 50 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 20 hours 40 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
